2348.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 16:07):

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally...

Stats
本日の出来高	116 000
平均出来高	286 540
時価総額	1.79B
EPS	HKD0 ( 2023-08-25 )
次の収益日	( HKD0 ) 2024-05-24
Last Dividend	HKD0.0150 ( 2023-09-19 )
Next Dividend	HKD0 ( N/A )
P/E	5.17
ATR14	HKD0 (0.00%)

Dawnrays Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Dawnrays Pharmaceutical 財務諸表

Annual	2023
収益:	HKD1.15B
総利益:	HKD641.52M (55.73 %)
EPS:	HKD0.220

FY	2023
収益:	HKD1.15B
総利益:	HKD641.52M (55.73 %)
EPS:	HKD0.220

FY	2022
収益:	HKD1.28B
総利益:	HKD766.68M (60.01 %)
EPS:	HKD0.240

FY	2021
収益:	HKD1.17B
総利益:	HKD681.26M (58.47 %)
EPS:	HKD0.230

Financial Reports:

No articles found.

Dawnrays Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0150 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0730 (N/A)	HKD0.0150 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Dawnrays Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.88 - good (98.76%) | Divividend Growth Potential Score: 6.07 - Stable (21.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00750	2003-10-17
Last Dividend	HKD0.0150	2023-09-19
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	40	--
Total Paid Out	HKD0.998	--
Avg. Dividend % Per Year	0.00%	--
Score	3.29	--
Div. Sustainability Score	9.88
Div.Growth Potential Score	6.07
Div. Directional Score	7.97	--

Next Divdend (Est)
(2024-07-03)

HKD0.0131 Estimate 12.35 %

Dividend Stability

0.49 Below Average

Dividend Score

3.29

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2362.HK	No Dividend Player	2023-06-01	Annually	0.00%
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
6677.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
1899.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
0927.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.283	1.500	4.34	6.50	[0 - 0.5]
returnOnAssetsTTM	0.0900	1.200	7.00	8.40	[0 - 0.3]
returnOnEquityTTM	0.115	1.500	9.83	10.00	[0.1 - 1]
payoutRatioTTM	0.359	-1.000	6.41	-6.41	[0 - 1]
currentRatioTTM	2.57	0.800	2.14	1.714	[1 - 3]
quickRatioTTM	2.08	0.800	2.49	1.995	[0.8 - 2.5]
cashRatioTTM	1.354	1.500	3.59	5.38	[0.2 - 2]
debtRatioTTM	0.0333	-1.500	9.45	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.226	2.00	9.92	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0926	2.00	9.95	10.00	[0 - 20]
debtEquityRatioTTM	0.0422	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.546	1.000	4.23	4.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.240	1.000	7.20	7.20	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.81	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.318	0.800	-1.215	-0.972	[0.5 - 2]
Total Score				9.88

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.11	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.115	2.50	9.89	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0926	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	7.93	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.226	2.00	9.92	10.00	[0 - 30]
payoutRatioTTM	0.359	1.500	6.41	-6.41	[0 - 1]
pegRatioTTM	0.134	1.500	-2.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.294	1.000	5.15	0	[0.1 - 0.5]
Total Score				6.07

Dawnrays Pharmaceutical

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.